Posters
Results with a hydrophobic trifocal IOL with an intermediate focus at 60 cm
Poster Details
First Author: R.Lapid-Gortzak THE NETHERLANDS
Co Author(s): I. van der Meulen C. Nieuwendaal V. Vrijman J. van der Linden
Abstract Details
Purpose:
To report the results of implantation of the TFNT00 trifocal hydrophobic IOL in terms of visual and refractive outcomes and side effects.
Setting:
Retina Total Eye Care, Driebergen, the Netherlands
Methods:
A case cohort study of eyes implanted with the TFNT00 IOL (Alcon, Fort Worth, USA). Results at 3 months where analyzed. Outcome parameters are uncorrected and corrected visual acuity at distance (UCDA and CDA), intermediate and near (DCIVA and UNVA and DCNVA), defocus curve, post-operative refraction, and incidence of residual refraction, and complications, as well as patient satisfaction.
Results:
In 114 eyes the TFNT00 was implanted. The mean spherical equivalent postoperative refraction was 0,03D 0.25 (range �,5 to -0,625 D). UCDA was logMAR -0.01 0.1, CDA was logMAR -0.09 0.05, DCIVA at 67cm was logMAR 0.06 0.06, DCNVA at 40 cm was -0.04 0,03, and UNVA was -0,05 0,1 logMAR at 40 cm. Incidence of residual refraction needing a touch up was low, the need for an early YAG capsulotomy was seen in some patients. 93% of patients were satisfied. 2 patients were lost to follow up.
Conclusions:
The hydrophobic non-apodized trifocal IOL with an intermediate focus at 60 cm, achieves good distance, intermediate and near visual acuity. Side effects are similar to those seen in other multifocal IOLs. Long-term efficacy needs to be studied.
Financial Disclosure:
receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company
